117 related articles for article (PubMed ID: 11856509)
21. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan.
Mizuo H; Yazaki Y; Sugawara K; Tsuda F; Takahashi M; Nishizawa T; Okamoto H
J Med Virol; 2005 Jul; 76(3):341-9. PubMed ID: 15902701
[TBL] [Abstract][Full Text] [Related]
22. [Study of severe hepatitis treated with a hybrid artificial liver support system].
Li LJ; Yang Q; Huang JR; Li J; Cao HC; Chen YM; Chen YG; Cheng JF; Fu SZ
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):458-60. PubMed ID: 12939173
[TBL] [Abstract][Full Text] [Related]
23. Serum amylase in viral hepatitis.
Pal AK; Krishnan S; Bose M
J Assoc Physicians India; 1983 Feb; 31(2):83-6. PubMed ID: 6193094
[No Abstract] [Full Text] [Related]
24. [An inquiry into the relationship among pathology, clinic and laboratory indexes of the severe viral hepatitis].
Meng Q; Liu D; Xiang H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Jun; 15(2):143-6. PubMed ID: 11436643
[TBL] [Abstract][Full Text] [Related]
25. Albumin-based dialysis as an effective treatment for severe traumatic hepatic necrosis.
Ben-Abraham R; Szold O; Nimrod A; Sorkine P
Isr Med Assoc J; 2003 Jun; 5(6):455-6. PubMed ID: 12841026
[No Abstract] [Full Text] [Related]
26. [Biochemical characterization of viral hepatitis in humans, using and not using narcotics].
Tomilka GS; Zhuravlev IaA; Gordinskaia NM
Ter Arkh; 2002; 74(11):6-10. PubMed ID: 12498114
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure].
Wang YJ; He NH; Niu RZ; Liu J; Wen HW; Li JJ; Wang YM
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):461-3. PubMed ID: 12939175
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters.
Bektas M; Idilman R; Soykan I; Soydan E; Arat M; Cinar K; Coban S; Tuzun A; Bozkaya H; Ormeci N; Ozden A
J Clin Gastroenterol; 2008; 42(5):517-21. PubMed ID: 18344887
[TBL] [Abstract][Full Text] [Related]
29. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver.
van de Kerkhove MP; Di Florio E; Scuderi V; Mancini A; Belli A; Bracco A; Scala D; Scala S; Zeuli L; Di Nicuolo G; Amoroso P; Calise F; Chamuleau RA
Cell Transplant; 2003; 12(6):563-8. PubMed ID: 14579924
[TBL] [Abstract][Full Text] [Related]
30. [5-nucleotidase activity in viral hepatitis].
Radzevich IM; Tat'ianko NV
Vrach Delo; 1980 Feb; (2):110-3. PubMed ID: 6245537
[No Abstract] [Full Text] [Related]
31. Abnormal liver enzymes 2-3 months after liver transplantation in a patient with hepatitis C: Report of a case.
Watt KD
Liver Transpl; 2006 Nov; 12(11 Suppl 2):S29-31. PubMed ID: 17051568
[No Abstract] [Full Text] [Related]
32. [Problems of expert testimony in chronic hepatitis].
Hofmann H
Dtsch Z Verdau Stoffwechselkr; 1967 Nov; 27(3):97-101. PubMed ID: 5595736
[No Abstract] [Full Text] [Related]
33. [Application of artificial liver support system in orthotopic liver transplantation].
Huang JR
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):505. PubMed ID: 12939193
[No Abstract] [Full Text] [Related]
34. Artificial liver support system in China: a review over the last 30 years.
Li LJ; Zhang YM; Liu XL; Du WB; Huang JR; Yang Q; Xu XW; Chen YM
Ther Apher Dial; 2006 Apr; 10(2):160-7. PubMed ID: 16684218
[TBL] [Abstract][Full Text] [Related]
35. Liver synthetic function in predicting the prognosis of pregnancy complicating fulminant hepatitis.
Li XM; Deng LZ; Shen HM; Yang YB; Li MX; Chen XW; Yin YZ; Zhou SS
Chin Med J (Engl); 2007 Dec; 120(24):2311-3. PubMed ID: 18167224
[No Abstract] [Full Text] [Related]
36. [The value of MELD in the assessment of short-term prognosis of severe hepatitis by artificial liver treatment].
Li N; Gao YF; Su F; Cui MF; Zhang TC; Chen P
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):469-70. PubMed ID: 22053382
[No Abstract] [Full Text] [Related]
37. [Influence of pyridoxal phosphate in measuring aminotransferases activities in patients with viral hepatitis].
Férard G; Imbert-Bismut F; Messous D; Piton A; Abella A; Burnat P; Hainque B; Glasser N; Lessinger JM
Ann Biol Clin (Paris); 2004; 62(6):717-20. PubMed ID: 15563433
[TBL] [Abstract][Full Text] [Related]
38. Incidence of statin hepatotoxicity in patients with hepatitis C.
Khorashadi S; Hasson NK; Cheung RC
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):902-7; quiz 806. PubMed ID: 16697272
[TBL] [Abstract][Full Text] [Related]
39. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.
Borroni G; Ceriani R; Cazzaniga M; Tommasini M; Roncalli M; Maltempo C; Felline C; Salerno F
Aliment Pharmacol Ther; 2006 Sep; 24(5):797-804. PubMed ID: 16918883
[TBL] [Abstract][Full Text] [Related]
40. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
